Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study

摘要

Background Hemodialysis services in Vietnam are being decentralised outside of tertiary hospitals. To identify the challenges to infection control standards for the prevention of bloodborne infections including hepatitis B virus (HBV) and hepatitis C virus (HCV) we tested the magnitude of HBV and HCV infections in the largest unit in Ho Chi Minh City servicing patients with end stage renal disease. Methods All 113 patients provided consent HBV surface antigen (HBsAg) and HCV core antigen (HCV-coreAg) testing. Positive patients were tested for viral genotypes. All participants completed a questionnaire on demographic characteristics, risk factors and previous attendance to other hemodialysis units. Results Seroprevalence of 113 patients enrolled was 7% (8/113, 95% CI 2.3%-11.8%) HBsAg, 6% (7/113, 95% CI 1.7%-10.6%) HCV-coreAg and 1% (1/113, 95% CI 0.8%-2.6%) co-infection. Having a HBV positive sexual partner significantly increased the risk of acquiring HBV (P?=?0.016, Odds Ratio (OR) =29, 95% CI 2–365). Risk factors for HCV included blood transfusion (P?=?0.049), multiple visits to different hemodialysis units (P?=?0.048, OR?=?5.7, 95% CI 1.2–27.5), frequency of hemodialysis (P?=?0.029) and AST plasma levels >40?IU/L (P?=?0.020, OR?=?19.8, 95% CI 2.3–171). On multivariate analysis only blood transfusion remained significant risk factor for HCV (P?=?0.027, adjusted OR?=?1.2). Conclusions HCV screening for HCV of blood products must improve to meet the infection prevention challenges of decentralizing hemodialysis services. The level of HCV and HBV in our hemodialysis unit is a warning that universal precautions will be the next challenge for decentralised hemodialysis services in Vietnam.